Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. It is developing technologies relating to imagery and light concentration for lens and image capture systems. The Company's primary focus is its patented and patent pending AI for imaging called All Light Intelligent Imaging Solutions (Aliis). Aliis can reduce storage and streaming requirements needed for videos and images while also improving image quality in all types of environmental conditions. Aliis delivers by learning a camera profile and optimally enhancing, pixel by pixel, its quality and its resolution in a fraction of a second, using edge processing. Its NexCompress, a video compression enhancement solution, offers bandwidth and storage savings for video storage and streaming applications.


TSXV:NXO - Post by User

Comment by Damn1212on Mar 07, 2022 9:59am
102 Views
Post# 34490002

RE:Pristine Surgical FDA report

RE:Pristine Surgical FDA reportSorry bill 

That doesnt mean its been approved by FDA for Medical use. 

Nice try though ! 

BTW 

Pristine medical had to borrow  15 million $ .... Why ? Probably they had too much money ? LOL No Sales ... LOL 

They also raised 18 million in 2020$ .... Since then 0 sales ... LOL  Ouchh 



MIAMIMarch 2, 2022 /PRNewswire/ -- Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed a $15 million Series D (Series A4) financing round for Pristine Surgical. Pristine Surgical will apply the funding toward commercialization of its single-use visualization platform developed for surgical and diagnostic endoscopic procedures.

"Pristine Surgical has brought the endoscope into the 21st Century, improving the endoscopic procedure for both patient and surgeon," said Mark Goldwasser, CEO of Ceros Financial Services.

Ceros focuses on fundraising for early-stage medical technology and medical device companies that are developing disruptive technologies, particularly for diagnostic and non-invasive procedures.  The firm is targeting to raise $150 million this year, Goldwasser said.  Ceros completed $117 million in transactions in the medtech sector in 2021 and $145 million since 2020. 



<< Previous
Bullboard Posts
Next >>